News & Videos - RESMED INC.

Research on Treating Sleep Apnea with Adaptive Servo-ventilation Published in the Journal of the American College of Cardiology (JACC) ResMed's CAT-HF study identifies potential treatment for heart failure patients with preserved ejection fraction and sleep apnea PR Newswire SAN DIEGO, March 20, 2017 SAN DIEGO , March 20, 2017 /PRNewswire/ -- ResMed (NYSE:RMD) today announced publication of a study in the Journal of the American College of Cardiology (JACC), which investigated whether treatment...

ResMed Named Global Leader in Remote Patient Monitoring PR Newswire SAN DIEGO, Feb. 13, 2017 7.1 million patients worldwide are remotely monitored, 2 million from ResMed alone SAN DIEGO , Feb. 13, 2017 /PRNewswire/ -- ResMed's global lead in remote patient monitoring kept growing in 2016, even as the industry itself continued to expand, according to the annual mHealth & Home Monitoring report released by independent technology analyst firm Berg Insight. Roughly 7.1 million patients were remotely...

VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ......

ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2017 Revenue increased 17% to $530.4 million; up 18% on a constant currency basis GAAP diluted earnings per share of $0.54; non-GAAP diluted earnings per share of $0.73 Operating cash flow of $119.9 million in the second quarter PR Newswire SAN DIEGO, Jan. 23, 2017 SAN DIEGO , Jan. 23, 2017 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended December 31, 2016 . Revenue for the quarter was $530.4...

ResMed and BMC/3B Medical Settle Global Litigation PR Newswire SAN DIEGO, Jan. 23, 2017 - Settlement ends all existing claims between ResMed and BMC/3B Medical - BMC and 3B will pay royalties to ResMed - ResMed makes one-time payment to 3B to resolve Florida litigation SAN DIEGO , Jan. 23, 2017 /PRNewswire/ -- ResMed (NYSE: RMD), BMC ( Beijing, China ) and 3B Medical ( Winter Haven, Florida ) today announced they have agreed on a global settlement of all litigation between the parties. BMC and...

ResMed and BMC/3B Medical Settle Global Litigation - Settlement ends all existing claims between ResMed and BMC/3B Medical - BMC and 3B will pay royalties to ResMed - ResMed makes one-time payment to 3B to resolve Florida litigation PR Newswire SAN DIEGO, Jan. 23, 2017 SAN DIEGO , Jan. 23, 2017 /PRNewswire/ -- ResMed (NYSE: RMD), BMC ( Beijing, China ) and 3B Medical ( Winter Haven, Florida ) today announced they have agreed on a global settlement of all litigation between the parties. BMC and...

ResMed et BMC / 3B Medical règlent un procès mondial PR Newswire SAN DIEGO, 23 janvier 2017 - La décision met un terme à toutes les demandes existantes entre ResMed et BMC / 3B Medical - BMC et 3B payeront des droits à ResMed - ResMed effectue un paiement unique à 3B pour résoudre le litige en Floride SAN DIEGO , 23 janvier 2017 /PRNewswire/ -- ResMed (NYSE : RMD), BMC (Pékin, Chine) et 3B Medical ( Winter Haven , Floride) ont annoncé aujourd'hui qu'ils se sont mis d'accord sur le...

ResMed und BMC/3B Medical legen globale Rechtsstreitigkeiten bei PR Newswire SAN DIEGO, 23. Januar 2017 - Vergleich regelt alle bestehenden Forderungen zwischen ResMed und BMC/3B Medical - BMC und 3B werden Lizenzgebühren an ResMed entrichten - ResMed leistet Einmalzahlung an 3B zur Verfahrensbeilegung in Florida SAN DIEGO , 23. Januar 2017 /PRNewswire/ -- ResMed (NYSE: RMD), BMC (Peking, China ) und 3B Medical ( Winter Haven, Florida ) gaben heute bekannt, dass sie sich auf eine Vereinbarung...

ResMed and BMC/3B Medical Settle Global Litigation - Settlement ends all existing claims between ResMed and BMC/3B Medical - BMC and 3B will pay royalties to ResMed - ResMed makes one-time payment to 3B to resolve Florida litigation PR Newswire SAN DIEGO, Jan. 20, 2017 SAN DIEGO , Jan. 20, 2017 /PRNewswire/ -- ResMed (NYSE:RMD), BMC ( Beijing, China ) and 3B Medical ( Winter Haven, Florida ) today announced they have agreed on a global settlement of all litigation between the parties. BMC and 3B...

ResMed's myAir™ Significantly Improves Adherence to CPAP Therapy in Patients with Sleep Apnea New study: Engaging patients with digital self-monitoring in their treatment improves adherence PR Newswire LONDON, Jan. 12, 2017 LONDON , Jan. 12, 2017 /PRNewswire/ -- ResMed (NYSE:RMD) today announced new European research from Price Waterhouse Coopers (PwC), revealing that patients with sleep apnea who use ResMed's myAir have greater adherence to CPAP (continuous positive airway pressure) therapy...

FDA Clears World's Smallest CPAP, ResMed AirMini™ Portable AirMini offers ease-of-use and comfort for travelers and additional revenue opportunities for home medical equipment providers PR Newswire SAN FRANCISCO, Jan. 9, 2017 SAN FRANCISCO , Jan. 9, 2017 /PRNewswire/ -- ResMed (NYSE:RMD) announced today at the 35 th annual J.P. Morgan Healthcare Conference that the U.S. Food and Drug Administration has cleared ResMed's AirMini, the world's smallest continuous positive airway pressure (CPAP)...

Dr. Oz, ResMed Launch SleepScore Labs - Promising the World a Better Night's Sleep PR Newswire LAS VEGAS, Jan. 6, 2017 LAS VEGAS , Jan. 6, 2017 /PRNewswire/ -- The world is about to find out how well it really sleeps – and how to sleep better – thanks to SleepScore Labs, a new company focused on helping people understand and improve their sleep. SleepScore Labs is a joint venture between renowned surgeon and television host Dr. Mehmet Oz ; ResMed (NYSE:RMD), the global leader in medical...

ResMed Reaches Historic One Billionth Night of Sleep Monitored PR Newswire SAN DIEGO, Jan. 4, 2017 - World's largest repository of sleep data – a giant step forward for sleep medicine - Predictive analytics from data will improve therapy and outcomes for sleep patients - Milestone reinforces ResMed's leadership in remote patient monitoring industry SAN DIEGO , Jan. 4, 2017 /PRNewswire/ -- ResMed (NYSE:RMD) today announced that it has achieved a new record in digital connected care: One billion...

ResMed Appoints Carlos Nunez, MD, as Chief Medical Officer PR Newswire SAN DIEGO, Dec. 20, 2016 SAN DIEGO , Dec. 20, 2016 /PRNewswire/ -- ResMed (NYSE: RMD) today announced that industry leader Carlos M. Nunez , MD, will become ResMed's chief medical officer, effective January 3, 2017 . Nunez most recently served as senior vice president of medical affairs for Becton, Dickinson and Company. He will be based in ResMed's San Diego headquarters and will report directly to CEO Mick Farrell and...

ResMed to Announce Second Quarter Fiscal Year 2017 Results PR Newswire SAN DIEGO, Dec. 19, 2016 SAN DIEGO , Dec. 19, 2016 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced it will report its second quarter of fiscal year 2017 results on Monday, January 23, 2017 after the New York Stock Exchange market closes. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook. The earnings...

WINTER HAVEN, Fla., Dec. 02, 2016 (GLOBE NEWSWIRE) -- 3B Medical, Inc. announces that an Administrative Law Judge of the United States International Trade Commission has issued an Initial Determination that ResMed (RMD) failed to satisfy the domestic industry requirement for patents relating to its CPAP masks and nasal pillow products, manufactured in Australia, Singapore and Malaysia. Gary Hnath of Mayer Brown, counsel for 3B/BMC, successfully argued that ResMed did not demonstrate sufficient...

ResMed Launches AirView Action Groups, the Ultimate Time-saver For Home Medical Equipment Providers PR Newswire ATLANTA, Nov. 1, 2016 AirView also now widely available for Astral life support ventilators, the first and only ventilator connectivity of its kind ATLANTA , Nov. 1, 2016 /PRNewswire/ -- ResMed (NYSE:RMD) today announced two enhancements to AirView™, the world's largest cloud-based remote patient monitoring platform that enables care teams to securely access therapy data from three...

ResMed Introduces AirFit™ N20 and AirFit F20 CPAP Masks: A New Standard for Fit and Comfort Including breakthrough InfinitySeal™ silicone cushion for unprecedented fit PR Newswire ATLANTA, Nov. 1, 2016 ATLANTA , Nov. 1, 2016 /PRNewswire/ -- ResMed (NYSE:RMD) today introduced the AirFit N20 nasal mask and AirFit F20 full face mask for positive airway pressure (PAP) treatment of sleep apnea. Loaded with innovations designed to improve mask fit, comfort and ease of use, the new-generation...

ResMed Inc. Announces Results for the First Quarter of Fiscal Year 2017 Revenue increased 13% to $465.4 million; also up 13% on a constant currency basis GAAP diluted earnings per share of $0.54; non-GAAP diluted earnings per share of $0.62 Operating cash flow of $86.2 million in the first quarter PR Newswire SAN DIEGO, Oct. 25, 2016 SAN DIEGO , Oct. 25, 2016 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended September 30, 2016 . Revenue for the quarter was...

Results from World's Largest Study on Sleep Apnea and Digital Connected Care ResMed's 128,000-patient study shows that digital self-monitoring and clinical management tools improve patients' adherence to treatment - one of the biggest issues in healthcare today Poor adherence or non-adherence to medical treatment costs an estimated $290 billion annually in the U.S.1 It limits effective management and control of chronic illnesses, increases the likelihood of preventable disease progression, and...